What Are FES PET Scans and How Are They Used for Lobular Breast Cancer?
Lobular breast cancer is most commonly estrogen receptor positive (ER+) and spreads to different parts of the body compared to ductal breast cancer. Lobular...
Read MoreWhat’s the Difference Between Targeted Therapy and Chemotherapy?
When you and your doctor talk about your treatment, you may hear terms such as “targeted therapy” and “chemotherapy”. Do you know the differences between how...
Read MoreAdvanced Breast Cancer Seventh International Consensus Conference (ABC7)
The ABC7 Global Alliance meeting for advanced breast cancer was held November 9-11, 2023 in Lisbon, Portugal. Click the links below for information discussed at...
Read MoreInvasive Lobular Breast Cancer Symposium 2023
The Invasive Lobular Breast Cancer Symposium was held September 28-30, 2023 in Pittsburgh, PA. Read below for news from this meeting. Lobular Breast Cancer...
Read MorePreparing for San Antonio Breast Cancer Symposium (SABCS) 2023
The San Antonio Breast Cancer Symposium (SABCS) is here (December 5-9, 2023) and is being held virtually and in-person. Information about registering for SABCS...
Read MoreHow Does a Clinical Trial Benefit Me?
Clinical trials should be considered a routine option for cancer care. Always ask your doctor about clinical trials to ensure you are considering all of your...
Read MoreFDA Approves Truqap
On November 16, 2023, the FDA approved capivasertib (Truqap™, AstraZeneca Pharmaceuticals) in combination with fulvestrant (Faslodex®) and a companion diagnostic...
Read MoreOur New Partner: GRASP
Our newest Metastatic Trial Search partner is Guiding Researchers and Advocates to Scientific Partnerships (GRASP). This organization aims to connect patient...
Read MoreOur New Partner: Unite for HER
Our newest Metastatic Trial Search partner is Unite for HER. This organization provides integrative therapies such as nutrition, acupuncture, massage, yoga, and...
Read MoreSEARCH OUR SITE
for past articles or specific information.